LT13 - Heterogeneity in cancer Flashcards

1
Q

intratumor heterogenity

A

several clones inside a tumor mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Intertumor heterogenity

A

different tumors in one patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

does a strong immune response to a tumor a better or worse clinical outcome?

A

Better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mostly mutated in CRC:

A

APC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mostly mutated in breast cancer:

A

CDH1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

often mutated in both CRC and breast cancer

A

TP53 and PIK3CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HER2 is often mutated in:

A

Breast- and urothelial cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Therapy against HER2 mutation cancers

A

trastuzumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why cant EGFR, KRAS and BRAF not be in the same pathway

A

they are oncogenes in the same pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A big percentage of CRC cancers is DNA repair proficient , this means

A

little mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drivers genes

A

Have high mutation frequency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Examples of drivers genes

A

APC, TP53, KRAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Passenger genes

A

have low mutation frequency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When does 5-FU only work?

A

in MMR-proficient tumors, because 5-FU needs to be incorperated into the DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly